PACLITAXEL - WHAT SCHEDULE - WHAT DOSE

被引：32

作者：

ARBUCK, SG

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 02期

关键词：

D O I：

10.1200/JCO.1994.12.2.233

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：233 / 236

页数：4

共 16 条

[1]

ARBUCK SG, 1993, SEMIN ONCOL, V20, P31

[2]

HILL BT, 1992, ANN ONCOL S1, V3, P120

[3]

HUININK WWT, 1993, OCT P TAX PACL NOV A, P20

[4] PHARMACOKINETICS OF PACLITAXEL AND METABOLITES IN A RANDOMIZED COMPARATIVE-STUDY IN PLATINUM-PRETREATED OVARIAN-CANCER PATIENTS [J].

HUIZING, MT ;

KEUNG, ACF ;

ROSING, H ;

VANDERKUIJ, V ;

HUININK, WWT ;

MANDJES, IM ;

DUBBELMAN, AC ;

PINEDO, HM ;

BEIJNEN, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2127-2135

[5] COMPARATIVE INVITRO CYTOTOXICITY OF TAXOL AND TAXOTERE AGAINST CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES [J].

KELLAND, LR ;

ABEL, G .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (06) :444-450

[6] CELL KILL KINETICS AND CELL-CYCLE EFFECTS OF TAXOL ON HUMAN AND HAMSTER OVARIAN CELL-LINES [J].

LOPES, NM ;

ADAMS, EG ;

PITTS, TW ;

BHUYAN, BK .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (03) :235-242

[7]

NABHOLTZ JM, 1993, P AN M AM SOC CLIN, V12, P60

[8]

PETTENGELL R, 1992, BLOOD, V80, P1430

[9]

ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1

[10]

SAROSY G, 1992, P AN M AM SOC CLIN, V11, P226

← 1 2 →